Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alcoholism | 11 | 2024 | 240 | 1.920 |
Why?
|
| Substance-Related Disorders | 16 | 2022 | 730 | 1.480 |
Why?
|
| Yoga | 3 | 2022 | 27 | 1.200 |
Why?
|
| Alcohol Drinking | 8 | 2023 | 519 | 1.110 |
Why?
|
| Meditation | 2 | 2022 | 26 | 1.030 |
Why?
|
| Mental Disorders | 5 | 2021 | 309 | 0.930 |
Why?
|
| Agrochemicals | 1 | 2021 | 4 | 0.810 |
Why?
|
| Hepatitis C | 1 | 2022 | 125 | 0.790 |
Why?
|
| Mental Health | 2 | 2022 | 303 | 0.780 |
Why?
|
| Emigration and Immigration | 1 | 2021 | 82 | 0.770 |
Why?
|
| Adolescent | 24 | 2023 | 5363 | 0.760 |
Why?
|
| Central Nervous System Stimulants | 1 | 2022 | 174 | 0.750 |
Why?
|
| Minority Groups | 6 | 2024 | 596 | 0.740 |
Why?
|
| Peer Group | 3 | 2023 | 156 | 0.700 |
Why?
|
| Humans | 44 | 2024 | 37093 | 0.630 |
Why?
|
| Bariatric Surgery | 4 | 2018 | 17 | 0.600 |
Why?
|
| Social Identification | 1 | 2015 | 58 | 0.500 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 103 | 0.500 |
Why?
|
| Prejudice | 1 | 2015 | 110 | 0.490 |
Why?
|
| Aggression | 1 | 2014 | 89 | 0.450 |
Why?
|
| Motivation | 5 | 2024 | 436 | 0.420 |
Why?
|
| Female | 21 | 2023 | 20969 | 0.410 |
Why?
|
| Male | 20 | 2023 | 20025 | 0.410 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2015 | 268 | 0.400 |
Why?
|
| Sexually Transmitted Diseases | 3 | 2018 | 164 | 0.400 |
Why?
|
| Adult | 15 | 2023 | 11712 | 0.380 |
Why?
|
| United States | 7 | 2023 | 4223 | 0.370 |
Why?
|
| Florida | 7 | 2022 | 410 | 0.360 |
Why?
|
| Health Promotion | 3 | 2018 | 653 | 0.350 |
Why?
|
| Adolescent Behavior | 4 | 2004 | 253 | 0.350 |
Why?
|
| Young Adult | 9 | 2024 | 4268 | 0.340 |
Why?
|
| Obesity, Morbid | 2 | 2018 | 23 | 0.320 |
Why?
|
| HIV Infections | 3 | 2020 | 2303 | 0.320 |
Why?
|
| Adolescent Development | 1 | 2008 | 31 | 0.310 |
Why?
|
| Social Work, Psychiatric | 2 | 2003 | 3 | 0.280 |
Why?
|
| Postoperative Complications | 2 | 2018 | 210 | 0.260 |
Why?
|
| Students | 3 | 2022 | 519 | 0.260 |
Why?
|
| Risk-Taking | 2 | 2004 | 451 | 0.230 |
Why?
|
| Crime Victims | 1 | 2004 | 77 | 0.230 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2008 | 98 | 0.230 |
Why?
|
| Drug and Narcotic Control | 1 | 2003 | 10 | 0.230 |
Why?
|
| Models, Organizational | 1 | 2003 | 32 | 0.220 |
Why?
|
| Violence | 1 | 2004 | 134 | 0.220 |
Why?
|
| Vaccination | 2 | 2022 | 288 | 0.220 |
Why?
|
| Patient Education as Topic | 1 | 2004 | 215 | 0.220 |
Why?
|
| Social Justice | 1 | 2003 | 55 | 0.220 |
Why?
|
| Narcotics | 1 | 2022 | 32 | 0.220 |
Why?
|
| Interpersonal Relations | 1 | 2004 | 205 | 0.220 |
Why?
|
| Culture | 2 | 2019 | 173 | 0.210 |
Why?
|
| Occupations | 1 | 2021 | 23 | 0.200 |
Why?
|
| Ethanol | 1 | 2023 | 192 | 0.190 |
Why?
|
| Concept Formation | 1 | 2021 | 20 | 0.190 |
Why?
|
| Longevity | 1 | 2022 | 147 | 0.190 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 169 | 0.190 |
Why?
|
| Juvenile Delinquency | 2 | 2016 | 44 | 0.190 |
Why?
|
| Education, Pharmacy | 1 | 2021 | 43 | 0.190 |
Why?
|
| Students, Pharmacy | 1 | 2021 | 47 | 0.180 |
Why?
|
| Pilot Projects | 1 | 2022 | 661 | 0.180 |
Why?
|
| Directive Counseling | 2 | 2014 | 14 | 0.170 |
Why?
|
| Adaptation, Psychological | 2 | 2018 | 385 | 0.170 |
Why?
|
| Focus Groups | 2 | 2018 | 348 | 0.170 |
Why?
|
| Condoms | 1 | 2020 | 135 | 0.170 |
Why?
|
| Refugees | 1 | 2019 | 19 | 0.170 |
Why?
|
| Child | 4 | 2022 | 3131 | 0.170 |
Why?
|
| Student Health Services | 1 | 2018 | 11 | 0.160 |
Why?
|
| Counseling | 1 | 1999 | 116 | 0.160 |
Why?
|
| Anxiety | 2 | 2022 | 754 | 0.160 |
Why?
|
| Schools | 2 | 2014 | 260 | 0.160 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 485 | 0.160 |
Why?
|
| Patient Selection | 1 | 2019 | 164 | 0.160 |
Why?
|
| Program Evaluation | 1 | 1999 | 339 | 0.150 |
Why?
|
| Spinal Dysraphism | 1 | 2017 | 6 | 0.150 |
Why?
|
| Cerebral Palsy | 1 | 2017 | 12 | 0.150 |
Why?
|
| Cultural Competency | 1 | 2018 | 131 | 0.150 |
Why?
|
| Perception | 1 | 2018 | 195 | 0.150 |
Why?
|
| Developmental Disabilities | 1 | 2017 | 61 | 0.140 |
Why?
|
| Prevalence | 6 | 2019 | 1455 | 0.140 |
Why?
|
| Criminals | 1 | 2016 | 15 | 0.140 |
Why?
|
| Hypertension | 1 | 2023 | 796 | 0.140 |
Why?
|
| Alcohols | 1 | 2016 | 12 | 0.140 |
Why?
|
| Needs Assessment | 1 | 2017 | 170 | 0.140 |
Why?
|
| Patient Preference | 1 | 2016 | 44 | 0.130 |
Why?
|
| Sexual Behavior | 3 | 2020 | 609 | 0.130 |
Why?
|
| Social Environment | 1 | 2016 | 207 | 0.120 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 276 | 0.120 |
Why?
|
| Depressive Disorder | 1 | 2016 | 174 | 0.120 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 404 | 0.120 |
Why?
|
| Treatment Outcome | 3 | 2008 | 1369 | 0.120 |
Why?
|
| Stress, Psychological | 1 | 1999 | 583 | 0.110 |
Why?
|
| Referral and Consultation | 1 | 2014 | 117 | 0.110 |
Why?
|
| Risk Factors | 7 | 2019 | 3562 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2015 | 400 | 0.090 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2016 | 389 | 0.090 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 974 | 0.080 |
Why?
|
| Ambulatory Care | 1 | 2008 | 75 | 0.080 |
Why?
|
| Models, Psychological | 2 | 2010 | 131 | 0.060 |
Why?
|
| Age Factors | 1 | 2008 | 1033 | 0.060 |
Why?
|
| Psychotherapy | 1 | 2004 | 47 | 0.060 |
Why?
|
| Cyclins | 1 | 2004 | 37 | 0.060 |
Why?
|
| Parents | 3 | 2016 | 329 | 0.060 |
Why?
|
| Sirolimus | 1 | 2004 | 60 | 0.060 |
Why?
|
| Human Rights | 1 | 2003 | 8 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2015 | 2026 | 0.060 |
Why?
|
| Harm Reduction | 1 | 2003 | 21 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2016 | 885 | 0.050 |
Why?
|
| Age of Onset | 1 | 2002 | 100 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 239 | 0.050 |
Why?
|
| Chi-Square Distribution | 1 | 2002 | 225 | 0.050 |
Why?
|
| Educational Status | 1 | 2023 | 313 | 0.050 |
Why?
|
| Health Policy | 1 | 2003 | 165 | 0.050 |
Why?
|
| Health Education | 1 | 2005 | 338 | 0.050 |
Why?
|
| Residence Characteristics | 1 | 2004 | 322 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2004 | 357 | 0.050 |
Why?
|
| Kidney | 1 | 2023 | 337 | 0.050 |
Why?
|
| Educational Measurement | 1 | 2021 | 86 | 0.050 |
Why?
|
| Pharmacists | 1 | 2021 | 53 | 0.050 |
Why?
|
| Cues | 1 | 2020 | 55 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2021 | 208 | 0.050 |
Why?
|
| Incidence | 1 | 2002 | 922 | 0.040 |
Why?
|
| Self Efficacy | 2 | 2016 | 184 | 0.040 |
Why?
|
| Demography | 1 | 1999 | 175 | 0.040 |
Why?
|
| Curriculum | 1 | 2021 | 265 | 0.040 |
Why?
|
| Forecasting | 1 | 1999 | 128 | 0.040 |
Why?
|
| Sex Factors | 1 | 2002 | 898 | 0.040 |
Why?
|
| Communication | 1 | 2020 | 180 | 0.040 |
Why?
|
| Universities | 1 | 2022 | 442 | 0.040 |
Why?
|
| Iran | 1 | 2019 | 190 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2018 | 27 | 0.040 |
Why?
|
| Mental Health Services | 1 | 2019 | 118 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2010 | 610 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2018 | 381 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2019 | 446 | 0.040 |
Why?
|
| Poverty | 1 | 2019 | 348 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2015 | 18 | 0.030 |
Why?
|
| Program Development | 1 | 2016 | 233 | 0.030 |
Why?
|
| Alcohol-Related Disorders | 1 | 2015 | 55 | 0.030 |
Why?
|
| Attention | 1 | 2016 | 156 | 0.030 |
Why?
|
| Social Support | 1 | 2016 | 394 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2015 | 1378 | 0.020 |
Why?
|
| Child Behavior Disorders | 1 | 2010 | 35 | 0.020 |
Why?
|
| Parent-Child Relations | 1 | 2010 | 110 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 864 | 0.020 |
Why?
|
| Models, Educational | 1 | 2005 | 44 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2004 | 1 | 0.020 |
Why?
|
| Cyclin D3 | 1 | 2004 | 3 | 0.020 |
Why?
|
| Ionomycin | 1 | 2004 | 10 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2004 | 7 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2004 | 41 | 0.020 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2004 | 27 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2004 | 79 | 0.020 |
Why?
|
| G1 Phase | 1 | 2004 | 33 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 96 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2004 | 121 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2004 | 236 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2003 | 195 | 0.010 |
Why?
|
| Psychotherapy, Brief | 1 | 2002 | 17 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 583 | 0.010 |
Why?
|
| Behavior Therapy | 1 | 2002 | 167 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 1742 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2003 | 2721 | 0.010 |
Why?
|